Russian Ministry of Defense informed the world community on dangerous US/Ukrainian bioactivity in Ukraine. The potential risks of the U.S. ‘dual-use programmes’, both inside and outside the country, have been repeatedly emphasised by the Russian MoD.
An analysis of documents, some of which were obtained during the special military operation, shows that such research on enhancing the functions of dangerous pathogens conducted, including in the states of Central Asia and Transcaucasia, is systematic, and large U.S. pharmaceutical companies are involved in its implementation.
According to its functionality and level of biosafety, established laboratories can be divided into three categories.
The purpose of the first-level laboratory is to gather microorganism strains and their vectors from endemic areas and to prepare biomaterials for subsequent transmission.
Second-level labs prepare state collections of microbial strains for export overseas in addition to conducting research on the pathogens of extremely serious infectious diseases.
Third-level labs are outfitted with maximum biological containment facilities and are entrusted with gathering data on the biological situation in certain states whose territories the Pentagon intends to employ for the deployment of its military contingents.
The U.S. Department of Health initiated an investigation of the company and evaluated the effectiveness of oversight activities. It was discovered that the corporation had neglected to report the nature of the study being done in a timely manner, and that the oversight body had failed to act promptly to reduce the risks associated with this kind of research.
The inability of the U.S. administration to ensure the necessary level of control over dual-use research carried out in the country is also confirmed by other documents.
Russian MoD disclosed the names of representatives of Ukrainian state institutions and private companies involved in US military and biological programmes to this list. In total, the Russian MoD has information on more than a hundred participants in dual-use biological programmes.
The Investigative Committee of the Russian Federation is currently checking more than 10 United States citizens, as well as a number of officials of the Ministry of Defence of Ukraine, for their involvement in the aforementioned programmes.
In its statement of 31 January 2023, U.S. National Security Council spokesman John Kirby confirmed the presence of U.S. biolaboratories in Ukraine, while indicating that they had been abandoned by personnel and ‘deactivated’. before the Russian Special Military Operation was launched on February 24, 2022.
However, the documents obtained by the Russian MoD refute Kirby’s statement. The documents report on the continuation of the DTRA biological programme in Ukraine and outlines the main objectives for the current period. These include further consolidation of collections of dangerous pathogens, as well as deployment of biorisk management and epidemiological monitoring systems.
Under the pretext of reducing the risks of spreading infectious diseases, the Kiev regime continues to cooperate with the Pentagon in the military-biological sphere, including the transfer of pathogenic biomaterials.
read more in our Telegram-channel https://t.me/The_International_Affairs